Century Therapeutics Inc (NASDAQ: IPSC) on Monday, soared 8.18% from the previous trading day, before settling in for the closing price of $0.51. Within the past 52 weeks, IPSC’s price has moved between $0.34 and $1.83.
Healthcare Sector giant saw their annual sales surged by 18.46% over the last five years. The company achieved an average annual earnings per share of 93.01%. With a float of $40.13 million, this company’s outstanding shares have now reached $86.32 million.
The firm has a total of 150 workers. Let’s measure their productivity.
Century Therapeutics Inc (IPSC) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Century Therapeutics Inc is 53.54%, while institutional ownership is 23.59%. The most recent insider transaction that took place on Sep 08 ’25, was worth 132. In this transaction SVP Finance & Operations of this company sold 263 shares at a rate of $0.50, taking the stock ownership to the 405,423 shares. Before that another transaction happened on Sep 08 ’25, when Company’s President and CEO sold 488 for $0.50, making the entire transaction worth $244. This insider now owns 3,268,909 shares in total.
Century Therapeutics Inc (IPSC) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.37 earnings per share (EPS) for the period topping the consensus outlook (set at -0.45) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 93.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.74% during the next five years compared to 18.46% growth over the previous five years of trading.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
Century Therapeutics Inc (IPSC) is currently performing well based on its current performance indicators. A quick ratio of 10.72 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Century Therapeutics Inc (IPSC)
Analysing the last 5-days average volume posted by the [Century Therapeutics Inc, IPSC], we can find that recorded value of 0.74 million was better than the volume posted last year of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 74.43%.
During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 41.90%, which indicates a significant decrease from 76.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0253 in the past 14 days, which was lower than the 0.0369 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5189, while its 200-day Moving Average is $0.6272. Now, the first resistance to watch is $0.5885. This is followed by the second major resistance level at $0.6216. The third major resistance level sits at $0.6634. If the price goes on to break the first support level at $0.5136, it is likely to go to the next support level at $0.4718. Now, if the price goes above the second support level, the third support stands at $0.4387.
Century Therapeutics Inc (NASDAQ: IPSC) Key Stats
Market capitalization of the company is 47.97 million based on 86,389K outstanding shares. Right now, sales total 6,590 K and income totals -126,570 K. The company made 109,160 K in profit during its latest quarter, and 76,560 K in sales during its previous quarter.
